Navigation Links
Mylan Receives FDA Approval for First-to-File Generic Depakote(R) ER
Date:1/30/2009

Company will have 180 days of marketing exclusivity on the 500 mg strength

PITTSBURGH, Jan. 30 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Divalproex Sodium Extended-release (Divalproex ER) Tablets, 250 mg and 500 mg.

Mylan has been awarded 180 days of marketing exclusivity for the 500 mg strength, which it will begin to ship Feb. 2. Mylan was the first company to file a substantially complete ANDA containing a Paragraph IV certification for the 500 mg strength. Mylan is shipping the 250 mg strength immediately.

Divalproex ER Tablets are the generic version of Abbott Laboratories' Depakote(R) ER and had U.S. sales of approximately $901 million for the 12 months ending Sept. 30, 2008, with $789 million for the 500 mg strength and $112 million for the 250 mg strength.

Currently, Mylan has 119 ANDAs pending FDA approval, 33 of which are potential first-to-file opportunities.

Mylan Inc., which provides products to customers in more than 140 countries and territories, ranks among the leading diversified generic and specialty pharmaceutical companies in the world. The company maintains one of the industry's broadest - and highest quality - product portfolios, supported by a robust product pipeline; owns a controlling interest in the world's third largest active pharmaceutical ingredient manufacturer; and operates a specialty business focused on respiratory and allergy therapies.


'/>"/>
SOURCE Mylan Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Mylan Declares Quarterly Preferred Stock Dividend
2. Mylan Receives Final FDA Approvals for Generic Versions of Lamictal(R) Tablets and Lamictal(R) CD
3. Mylan Receives Final FDA Approval for Generic Version of Prilosec(R) Delayed-Release Capsules, 40 mg
4. U.S. Patent and Trademark Office Issues Mylans Specialty Division, Dey L.P., Three Additional Patents Protecting Perforomist(R) Inhalation Solution
5. Mylan to Present at the 27th Annual J.P. Morgan Healthcare Conference
6. Mylans Matrix Receives Final FDA Approval for the Generic Version of the Antiretroviral Zerit(R) Capsules
7. Mylan Announces Move to NASDAQ Stock Market
8. Mylan Announces Settlement Agreement with Novartis Related to Femara(R) First- to-File Opportunity
9. Mylan Receives Final FDA Approval for the Generic Version of the Antidepressant Sarafem(R) Pulvules(R) Capsules
10. Mylan Receives Final Approval for First-to-File Generic Version of Antiepileptic Keppra(R) and Launches Immediately
11. Mylan Declares Quarterly Preferred Stock Dividend
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... Conn. (PRWEB) May 06, 2015 ... in Wethersfield, Conn., has hired healthcare executive Ann ... president. Olson will lead Qualidigm’s growing home ... Qualidigm’s mission to improve the quality, safety, and ... comes to Qualidigm from Interim HealthCare of North ...
(Date:5/6/2015)... 2015 The Center for Innovative Technology ... invested in e-Kare, Inc. of Fairfax, VA, a digital ... of chronic wounds. , Chronic wounds include pressure, venous, ... that affect over 6.5 million U.S. patients, costing over ... enterprise from the Children’s National Medical Center (CNMC), ...
(Date:5/6/2015)... Viejo, CA (PRWEB) May 06, 2015 ... unique and fun self-animating generators for Final Cut ... to add stylistic titles to a Final Cut Pro ... environments, adding professional quality openers to any shot has ... any skill level in mind, saving users time while ...
(Date:5/6/2015)... 06, 2015 Healthcare marketing agency ... a silver award in the 2015 Aster Awards for ... and Ellis Medicine’s maternity campaign, respectively. The Aster Awards ... organizations and marketing agencies. , The branding campaign ... line — other/misc. category and hospital 150-200 bed group. ...
(Date:5/6/2015)... NY (PRWEB) May 06, 2015 The ... in New York City, announced today that it was ... Awards for a presentation video produced on behalf of ... in the category of motion graphics. , The competition ... (AMCP), received over 6000 entries from 22 countries. ...
Breaking Medicine News(10 mins):Health News:Innovative Healthcare Executive Ann Olson Joins Qualidigm as Principal and Vice President 2Health News:Innovative Healthcare Executive Ann Olson Joins Qualidigm as Principal and Vice President 3Health News:CIT GAP Funds Invests in e-Kare 2Health News:CIT GAP Funds Invests in e-Kare 3Health News:Pixel Film Studios announces the release of Protrailer Cartoon Volume 2 for Final Cut Pro X. 2Health News:Smith & Jones Wins in 2015 Aster Awards for Healthcare Marketing 2Health News:The SGNY Group Wins Platinum Hermes Creative Award 2
... ... brought another family together for the holidays , ... (PRWEB) December 31, 2009 -- Celebrating the holidays under the grip of ... story evoking the true spirit of the holidays. "Before he began using drugs like ...
... ... year right , ... (PRWEB) -- Massage Envy , the nation’s largest massage therapy provider, recommends ringing in ... program. Along with resolving to eat healthier, take vitamins and exercise more frequently, incorporating ...
... a little extra incentive to kick the habit? Just ... that even after age 80, smoking continues to increase one,s ... blindness in Americans over 65. The ... January edition. "The take-home message is that it,s never ...
... , GAINESVILLE, Fla., ... the delegation at the Florida House on Capitol Hill in Washington, ... efforts to establish a gallery and learning center in Ft. Myers, ... while bridging differences and strengthening relationships. , (Photo: ...
... of the Streptococcus pneumoniae in samples that ... may predict risk of severe disease in H1N1 pandemic ... associated with higher morbidity and mortality than in other ... Immunity (CII) at the Mailman School of Public Health ...
... , , , , WOONSOCKET, ... will provide H1N1 flu vaccinations at select CVS/pharmacy ... and New York as well at MinuteClinic locations in Massachusetts ... ) , Public health officials are now encouraging everyone ...
Cached Medicine News:Health News:Mother and Son Spend Holidays Free of Drug Addiction 2Health News:Ring in a Healthy New Year with Massage Therapy in 2010 2Health News:It's never too late to quit smoking and save your vision 2Health News:Founders of the Sebastian Ferrero Foundation Join HSH Prince Albert II of Monaco in Support of the New Art of the Olympians Museum 2Health News:Founders of the Sebastian Ferrero Foundation Join HSH Prince Albert II of Monaco in Support of the New Art of the Olympians Museum 3Health News:Founders of the Sebastian Ferrero Foundation Join HSH Prince Albert II of Monaco in Support of the New Art of the Olympians Museum 4Health News:Severity of H1N1 influenza linked to presence of Streptococcus pneumoniae 2Health News:CVS/pharmacy and MinuteClinic to Provide H1N1 Vaccines in 8 New States 2Health News:CVS/pharmacy and MinuteClinic to Provide H1N1 Vaccines in 8 New States 3Health News:CVS/pharmacy and MinuteClinic to Provide H1N1 Vaccines in 8 New States 4
(Date:5/6/2015)... , May 6, 2015  Galmed Pharmaceuticals Ltd. (Nasdaq: ... on the development and commercialization of a once-daily, oral ... gallstones, announced today that it will host a conference ... discuss results for the period ended March 31, 2015 ... respect to its clinical program for aramchol. ...
(Date:5/6/2015)...   Sigma-Aldrich Corporation (NASDAQ: SIAL ) a ... a $50,000 product donation to the Reproducibility Project: ... findings from recent high-impact papers in the field of ... online research marketplace Science Exchange , the non-profit ... journal eLife. The goal of the project ...
(Date:5/6/2015)... -- First programme to evaluate ...   ViiV Healthcare today announced ... programme to evaluate the safety and efficacy of ... maintenance therapy for adult patients with HIV. The ... 48 week viral suppression with a two drug ...
Breaking Medicine Technology:Galmed Pharmaceuticals First Quarter 2015 Conference Call and Webcast Scheduled for Wednesday, May 13, 2015 2Galmed Pharmaceuticals First Quarter 2015 Conference Call and Webcast Scheduled for Wednesday, May 13, 2015 3Sigma-Aldrich Donates $50K in Products to the Reproducibility Project to Foster Replicable Research and Accelerate Scientific Discoveries in Cancer Biology 2Sigma-Aldrich Donates $50K in Products to the Reproducibility Project to Foster Replicable Research and Accelerate Scientific Discoveries in Cancer Biology 3ViiV Healthcare Begins Phase III Programme with dolutegravir/rilpivirine Combination for HIV Maintenance Therapy 2ViiV Healthcare Begins Phase III Programme with dolutegravir/rilpivirine Combination for HIV Maintenance Therapy 3ViiV Healthcare Begins Phase III Programme with dolutegravir/rilpivirine Combination for HIV Maintenance Therapy 4ViiV Healthcare Begins Phase III Programme with dolutegravir/rilpivirine Combination for HIV Maintenance Therapy 5ViiV Healthcare Begins Phase III Programme with dolutegravir/rilpivirine Combination for HIV Maintenance Therapy 6ViiV Healthcare Begins Phase III Programme with dolutegravir/rilpivirine Combination for HIV Maintenance Therapy 7ViiV Healthcare Begins Phase III Programme with dolutegravir/rilpivirine Combination for HIV Maintenance Therapy 8ViiV Healthcare Begins Phase III Programme with dolutegravir/rilpivirine Combination for HIV Maintenance Therapy 9ViiV Healthcare Begins Phase III Programme with dolutegravir/rilpivirine Combination for HIV Maintenance Therapy 10
... , CARLSBAD, Calif. , Aug. 3 Excaliard ... trial of EXC 001, a new chemical entity for reducing fibrosis. ... subjects undergoing an elective abdominoplasty compared to placebo.   , ... In ...
... ,, MUMBAI, India , August 3, 2010 MMRSS, which has ... Taiwan , Hong Kong and Singapore . , , ... MMRSS, which has a presence in India , China , Thailand , Indonesia , ... Asia and the Middle East to its clients. , ...
Cached Medicine Technology:Excaliard Announces Positive Data From Phase 2 Clinical Trial of Its Anti-Scarring Drug, EXC 001 2MMRSS now in Hong Kong, Singapore and Taiwan 2
The Elschnig teeth of this forceps are ideal for grasping sclera during suturing. Delicate tying platform handles the finest suture material. 0.12 mm, 1 x 2 teeth....
Jaws with fine teeth. Serrated handle with polished finish. Jaws: Wide, 4.5 mm. With thumb catch lock....
Straight shafts with heavy Elschnig teeth. Flat serrated handle with slide style lock and polished finished....
Serrated handle with polished finish. Non-magnetic. Straight tips: Delicate 11 mm. Most popular size or model....
Medicine Products: